GAMBACORTI PASSERINI CARLO

Zappaterra, A., Civettini, I., Cafro, A., Pezzetti, L., Pierini, S., Anghilieri, M., et al. (2024). Anti-CD38 monoclonal antibody impairs CD34+ mobilization and affects clonogenic potential in multiple myeloma patients. BLOOD TRANSFUSION, 1-13 [10.2450/BloodTransfus.667]. Dettaglio

Fontana, D., Zambrotta, G., Scannella, A., Piazza, R., Gambacorti-Passerini, C. (2024). Late relapse of chronic myeloid leukemia after allogeneic bone marrow transplantation points to KANSARL (KANSL1::ARL17A) alteration: a case report with insights on the molecular landscape. ANNALS OF HEMATOLOGY [10.1007/s00277-024-05649-4]. Dettaglio

Crespiatico, I., Zaghi, M., Mastini, C., D'Aliberti, D., Mauri, M., Mercado, C., et al. (2024). First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis. BLOOD [10.1182/blood.2023021349]. Dettaglio

Elli, E., Mauri, M., D’Aliberti, D., Crespiatico, I., Fontana, D., Redaelli, S., et al. (2024). Idiopathic erythrocytosis: a germline disease?. CLINICAL AND EXPERIMENTAL MEDICINE, 24(1) [10.1007/s10238-023-01283-y]. Dettaglio

Smith, B., Brümmendorf, T., Roboz, G., Gambacorti-Passerini, C., Charbonnier, A., Viqueira, A., et al. (2024). Efficacy and safety of bosutinib in patients treated with prior imatinib and/or dasatinib and/or nilotinib: Subgroup analyses from the phase 4 BYOND study. LEUKEMIA RESEARCH, 139(April 2024) [10.1016/j.leukres.2024.107481]. Dettaglio